Why Kyndryl Holdings Stock Dropped Today

Kyndryl missed Q4 expectations with EPS of $0.08 versus the $0.49 consensus and revenue below $3.8 billion versus just under $4 billion expected, sending the stock down 9.4%. Profit fell 71% year over year in the quarter and 19% for fiscal 2026, though sales were roughly flat and free cash flow remained strong at $406 million. Management expects fiscal 2027 free cash flow of $400 million to $500 million, implying up to 23% growth.

Analysis

KD’s miss reads less like a demand collapse and more like an operating leverage problem: when margins are this thin, a small step-up in taxes or SG&A can overwhelm apparently stable revenue. That makes the equity story fragile because the market is effectively underwriting a narrow band of “good enough” execution; any incremental cost pressure can produce a disproportionate earnings reset. In other words, KD is a cash-flow story, not an earnings-quality story, and the market is increasingly paying attention to the denominator rather than the numerator.

The more important second-order effect is that strong free cash flow gives management room to keep investing in transformation, buy back stock, or defend pricing, which can stabilize the multiple over time even if GAAP earnings remain noisy. If guidance for FY27 FCF holds, the selloff likely over-penalizes near-term EPS while underweighting the durability of cash conversion. Still, the path to rerating depends on proof that tax and overhead drag are transitory rather than a structural feature of the business mix.

The consensus may be missing that the current setup is asymmetric: downside from another quarter of low-single-digit margin slippage is real, but upside from FCF-driven capital returns and sentiment normalization could be meaningful if management delivers one or two clean prints. That said, this is not the kind of name where multiple expansion happens on narrative alone; it needs evidence that cost control is actually improving. The market is likely to keep punishing any disappointment for 1-2 quarters, so timing matters more than thesis here.

Key Decisions for Investors

• Avoid chasing KD on the first post-earnings bounce; wait 2-4 weeks for revisions and estimate cuts to clear, since near-term risk is another downgrade cycle rather than immediate recovery.
• For tactical long exposure, buy KD only on confirmation of FCF guidance at or above the midpoint on the next call; target a 10-15% upside re-rating if management shows SG&A leverage, with a stop if operating margin compresses again.
• Use KD as a relative-value short versus higher-quality IT services or infrastructure names with better margin visibility; the setup favors shorting the weakest earnings-quality story rather than the whole sector.